Hydrogen Sulfide SIBO Treatments and Case Studies

CAD$34.99

Course Approvals

Course Approvals

See credit status below for additional jurisdictions

Course Instructors

Course Topics

Course Duration

1 hour

Category:

Description

There is growing interest in small intestinal bacterial overgrowth (SIBO). In late 2020, a new diagnostic device for SIBO was released which added testing for hydrogen sulfide (H2S) gas. While this has spawned a burgeoning interest in H2S SIBO clinically, research is lacking. Basic questions including how clinicians are making the diagnosis, what symptoms are present, and what clinicians are using for treatment, remain unanswered. In this presentation we review the results of our case registry of over 100 H2S SIBO cases which represents the largest collection of H2S SIBO cases to-date, providing important early descriptive information on this emerging diagnosis and some clinically actionable findings in terms of diagnosis and treatment from our secondary and exploratory analyses. We also go through case study examples of H2S SIBO evaluation and management.

Learning Objectives

  1. Recall the most common symptoms which H2S patients present with
  2. Identify which H2S treatment interventions led to a statistically significant rate of adequate patient response
  3. Evaluate an H2S SIBO case with a focus on severity and treatment history
  4. Determine reasonable treatment options for an H2S SIBO case

 

Approved for 1.0 Category A Credit by the CONO.

Title: Hydrogen Sulfide SIBO: Treatments and Case Studies

Speaker: Dr. Joshua Goldenberg ND

CE Credit Status

Eligible
Qualifying Continuing Education by CTDPH (Connecticut)
Coursework by DORA (Colorado)
Credit hours by OBNM (Oregon)
Category C Credits by SNAP (Saskatchewan)
Program Credits CNDA (Alberta)
Category C Credits by CNPBC (British Columbia)

Reciprocal Approval
Arizona, USA
Quebec, New Brunswick, Nova Scotia, PEI, NewFoundland, CANADA